Lene Trinh
Research Scientist CataVax
Lene Trinh is a Research Scientist at Catavax, a pioneering biotech company developing the world’s first immunotherapy that reprograms CD4 T cells to kill cancer. She plays a key role in preclinical development, leading studies that validate Catavax’s innovative approach to harnessing immune system mechanisms for cancer treatment. Linh is passionate about advancing transformative therapies through rigorous research and collaboration.
Seminars
Monday 4th May 2026
Panel Discussion: Building a General Consensus on Model Selection Criteria Across Oncology Drug Development
3:00 pm
- Understanding the different tumour models used in drug discovery and development across the field
- Exploring the various questions and contexts of use for each main model type and how translatable and clinically relevant they truly are
- How did you overcome hurdles encountered with your model when trying to better understand your drug/target?
